These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7936902)

  • 1. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
    Garland J; Buck R; Weinberg M
    Pediatrics; 1994 Nov; 94(5):719-23. PubMed ID: 7936902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage.
    Pandit PB; Dunn MS; Colucci EA
    Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
    Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
    Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of pulmonary hemorrhage in very-low-birth-weight infants: a two-year retrospective study.
    Lin TW; Su BH; Lin HC; Hu PS; Peng CT; Tsai CH; Liang WM
    Acta Paediatr Taiwan; 2000; 41(5):255-8. PubMed ID: 11100523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
    Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
    Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait.
    Hammoud MS; Elsori HA; Hanafi EA; Shalabi AA; Fouda IA; Devarajan LV
    Saudi Med J; 2003 Sep; 24(9):982-5. PubMed ID: 12973483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic and pulmonary hemodynamics in the course of substitute therapy with exosurf neonatal in newborn infants with respiratory distress syndrome].
    Milenin OB; Efimov MS
    Anesteziol Reanimatol; 1996; (6):7-10. PubMed ID: 9045592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant replacement in neonates with early chronic lung disease.
    Pandit PB; Dunn MS; Kelly EN; Perlman M
    Pediatrics; 1995 Jun; 95(6):851-4. PubMed ID: 7761208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.